Gold bars to be exempt from tariffs, White House clarifies
Investing.com -- Siemens (ETR:SIEGn) Healthineers stated Monday that recent developments in China are not expected to materially impact its operations.
"Our strong presence in China is part of the global manufacturing footprint we have built up over the years to strategically serve local markets and ensure minimal disruption," a spokesperson for the German medical technology group said in a statement.
The statement comes after China’s finance ministry announced Sunday it would restrict government purchases of medical devices from the European Union exceeding 45 million yuan ($6.3 million) in value. These restrictions were implemented as retaliation to Brussels’ own curbs introduced last month.
Siemens Healthineers emphasized that its established global manufacturing network positions the company to continue serving markets with minimal disruption despite the new trade measures.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.